Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114973733 | 11497373 | 3 | F | 20160817 | 20150911 | 20160825 | EXP | BR-ALEXION PHARMACEUTICALS INC-A201503413 | ALEXION | 0.00 | Y | 0.00000 | 20160825 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114973733 | 11497373 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, UNK | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||
| 114973733 | 11497373 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, UNK | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||
| 114973733 | 11497373 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | UNK | 0 | ||||||||||
| 114973733 | 11497373 | 4 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | UNK | 0 | ||||||||||
| 114973733 | 11497373 | 5 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | UNK | 0 | ||||||||||
| 114973733 | 11497373 | 6 | C | APRESOLINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 114973733 | 11497373 | 7 | C | LASIX | FUROSEMIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114973733 | 11497373 | 1 | Haemolytic uraemic syndrome |
| 114973733 | 11497373 | 3 | Product used for unknown indication |
| 114973733 | 11497373 | 4 | Product used for unknown indication |
| 114973733 | 11497373 | 5 | Product used for unknown indication |
| 114973733 | 11497373 | 6 | Product used for unknown indication |
| 114973733 | 11497373 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114973733 | 11497373 | OT |
| 114973733 | 11497373 | HO |
| 114973733 | 11497373 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114973733 | 11497373 | Asthenia | |
| 114973733 | 11497373 | Cardiac failure congestive | |
| 114973733 | 11497373 | Condition aggravated | |
| 114973733 | 11497373 | Fatigue | |
| 114973733 | 11497373 | Hepatitis C | |
| 114973733 | 11497373 | Inappropriate schedule of drug administration | |
| 114973733 | 11497373 | Liver disorder | |
| 114973733 | 11497373 | Pyrexia | |
| 114973733 | 11497373 | Renal impairment | |
| 114973733 | 11497373 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114973733 | 11497373 | 1 | 20150206 | 20150227 | 0 | |
| 114973733 | 11497373 | 2 | 20150306 | 0 |